Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ami Patel

Assistant Professor

The Wistar Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

About

Dr. Ami Patel is an Assistant Professor at The Wistar Institute in the United States. Her research focuses on innovative therapeutic approaches, including DNA immunotherapy and in vivo delivery systems for monoclonal antibodies targeting various infectious diseases and tumors. Recent publications highlight her work on enhancing immune responses against SARS-CoV-2 and malaria, as well as exploring molecular therapies for cancer treatment.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Jianqiu Du

The Wistar Institute

UNITED STATES

View details

Jesper Pallesen

Assistant Professor

The Wistar Institute

UNITED STATES

View details

Mamadou Bah

The Wistar Institute

UNITED STATES

View details

Michele Kutzler

Professor of Medicine and Microbiology and Immunology

Drexel University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ami Patel

Research Interests

Explore related searches

About

Articles (10)

In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape

DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

Engineered DNA-encoded monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein confer single dose protection in a murine malaria challenge model

Molecular therapies and vaccines face the challenges of emerging infectious diseases

Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

Collaborators (4)

Jianqiu Du

Jesper Pallesen

Mamadou Bah

Michele Kutzler

Make your next move.